Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GSK’s Blenrep: 15 Days From Confirmatory Trial Failure To Withdrawal Announcement
Nov 28 2022
•
By
Sue Sutter
FDA and GSK moved with considerable speed in taking Blenrep off the market followed a failed confirmatory trial. • Source: Shutterstock
More from Review Pathways
More from Pathways & Standards